Abstract
BackgroundTakayasu arteritis(TA) is a large-vessel vasculitis1. Treatment is mainly based on steroids, but in approximately 50% of patients a disease-modifying antirheumatic drug(DMARD) is required2. Anti-TNFα agents are recommended for steroid...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
